tiprankstipranks
Trending News
More News >
Synlogic Inc (SYBX)
:SYBX
Advertisement

Synlogic (SYBX) Price & Analysis

Compare
561 Followers

SYBX Stock Chart & Stats

$1.73
$0.02(1.41%)
At close: 4:00 PM EST
$1.73
$0.02(1.41%)

Synlogic News

SYBX FAQ

What was Synlogic Inc’s price range in the past 12 months?
Synlogic Inc lowest stock price was $0.90 and its highest was $1.96 in the past 12 months.
    What is Synlogic Inc’s market cap?
    Synlogic Inc’s market cap is $18.60M.
      When is Synlogic Inc’s upcoming earnings report date?
      Synlogic Inc’s upcoming earnings report date is Nov 06, 2025 which is 6 days ago.
        How were Synlogic Inc’s earnings last quarter?
        Synlogic Inc released its earnings results on Aug 07, 2025. The company reported -$0.043 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.043.
          Is Synlogic Inc overvalued?
          According to Wall Street analysts Synlogic Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Synlogic Inc pay dividends?
            Synlogic Inc does not currently pay dividends.
            What is Synlogic Inc’s EPS estimate?
            Synlogic Inc’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Synlogic Inc have?
            Synlogic Inc has 11,698,919 shares outstanding.
              What happened to Synlogic Inc’s price movement after its last earnings report?
              Synlogic Inc reported an EPS of -$0.043 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 1.235%.
                Which hedge fund is a major shareholder of Synlogic Inc?
                Currently, no hedge funds are holding shares in SYBX

                Company Description

                Synlogic Inc

                Synlogic (SYBX) is a clinical-stage biotechnology company focused on the development of Synthetic Biotic medicines, which are designed to treat diseases by programming probiotics to perform or deliver therapeutic functions in the gut. These engineered probiotics aim to address metabolic and immunological diseases, offering potential treatment options for conditions that are inadequately managed by traditional pharmaceuticals.

                Synlogic (SYBX) Earnings & Revenues

                Similar Stocks
                Company
                Price & Change
                Follow
                Lisata Therapeutics
                Aptevo Therapeutics
                SeaStar Medical Holding
                Cingulate Inc
                Allarity Therapeutics

                Ownership Overview

                0.37%2.82%<0.01%95.28%
                <0.01% Other Institutional Investors
                95.28% Public Companies and
                Individual Investors

                Options Prices

                Currently, No data available
                ---
                Popular Stocks
                What am I Missing?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis